Stay updated on Dupilumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Minor layout and formatting changes observed on the Study Details page, with no changes to core study data (status, enrollment, endpoints, eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:11:59.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the version to v3.2.0; removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:08:49.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Added version tag v3.1.0 and removed several drug-safety topic sections; indicates content pruning in the drug-safety area with a version upgrade.
    Difference
    0.4%
    Check dated 2025-09-28T03:12:35.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed (a minor UI change).
    Difference
    0.2%
    Check dated 2025-09-13T17:16:23.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:55:46.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of specific facility names and locations in Germany, as well as new topics related to drug safety and skin conditions. Notably, the previous references to certain locations and topics have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:45:49.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.